1Keck PE, Versiani M, Potkin S, et al. Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized triaL Am J Psychiatry, 2003; 160 (4) : 741-748.
2Potldn SG, Keck PE Jr, Segal S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebocontrolled replication trial. J Clin Psychopharrnacol. 2005 ; 25 (4) : 301-10.
4Biederman J, Miek E, Spencer T, et al. A prospective openlabel treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord. 2007; 9 (8): 888-894.
5Papakostas GI, Shehon RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment, resistant major depressive disorder: a meta-analysis. J Clin Psychiatry, 2007; 68 (6) : 826-831.
6Dunner DL, Amsterdam JD, Shehon RC, et al. Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. J Clin Psychiatry, 2007; 68 (7): 1071-1077.
7Patel NC, Keek PE. Ziprasidone: efficacy and safety in patients with bipolar disorder. Expert Rev Neurother. 2006; 6 (8) : 1129-1138.
8Greenberg WM, Citrome L Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. CNS Drug Rev. 2007; 13 (2): 137-177.
9Warrington L, Lombardo I, l_oebel A, et al. Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder. CNS Drugs. 2007; 21 (10) : 835-849.
7KECK P E,VERSIANI M,POTKIN S,et al.Ziprasidone in Mania Study Group.Zip-rasidone in the treatment of Acute bipolar mania:a three-week,placebo-controlled,double-blind,randomized trial[J].Am J Psychiatry,2003,160(4):741-748.
8STIMMEL G L,GUITIERREZ M A,LEE V.Ziprasidone:an atypical antipsychotic drug for the treatment of schizop hrenia[J].Clin Ther,2002,24(1):21-23.
9BARNETT M S.Ziprasidone monotherapy in pediatric bipo-lar disorder[J].J Child Adolesc Psychopharrnacol,2004,14(3):471-477.
10FAVA M,THASE M E,DEBATTISTA C.A multicenter.Placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness[J].J Clin Psychiatry,2005,66(1):85-90.
